Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital... Show more
Marsh McLennan occupies a distinctive position as one of the world's largest professional-services franchises focused on risk, strategy, and people, with roughly $27 billion in annual revenue and operations in 130 countries. Its diversified model is a structural advantage: insurance broking and reinsurance generate resilient, fee-based revenue, while consulting (Mercer and Oliver Wyman) adds higher-growth, advisory-driven income that is less tied to underwriting cycles. This balance reduces the company's exposure to any single market trend and supports relatively stable margins across economic environments.
Scale and data are the core competitive moats. As the largest insurance broker and a top reinsurance intermediary, Marsh McLennan can leverage proprietary analytics, global placement networks, and deep client relationships that smaller rivals struggle to replicate. The ongoing brand consolidation under the single "Marsh" name is intended to sharpen go-to-market clarity and cross-selling across business lines. However, the medium-term outlook is nuanced: commercial property and casualty pricing has cooled in segments, and consulting demand remains sensitive to corporate discretionary budgets—factors that could limit organic revenue growth even as acquisitions sustain headline expansion.
Several forward-looking developments are likely to shape investor sentiment around MRSH:
Marsh McLennan's trajectory is closely tied to the broader insurance brokerage and professional-services ecosystem. Interest rates influence both investment returns and the affordability of insurance-linked capital; higher-for-longer rates generally support reinsurance economics, while easing inflation can slow premium-rate growth. Consumer and corporate demand cycles matter too—when businesses face tighter budgets, discretionary consulting and advisory spending can decelerate.
Geopolitical volatility and trade-policy uncertainty are, somewhat counterintuitively, potential tailwinds: rising risk complexity increases demand for risk-mitigation, insurance placement, and strategic consulting services. The same dynamic applies to cybersecurity threats and climate-related exposures, which continue to expand the addressable market for risk advisory work. On the other hand, elevated catastrophe losses can pressure reinsurance pricing and client costs, while a sustained decline in commercial property pricing represents the clearest near-term headwind. Regulatory shifts—including capital requirements and disclosure rules—could also alter demand patterns across the firm's global client base.
For traders seeking a forward-looking view of MRSH and similar securities, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool that helps identify whether a stock, ETF (exchange-traded fund), or other asset may move bullish, bearish, or sideways over the next week or month. The tool is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, with searchable prediction categories, historical context, and alert-oriented functionality. As part of a broader research process, it can complement fundamental analysis of names like MRSH.
Looking toward 2026 and beyond, several structural themes will define Marsh McLennan's future outlook. First, market expansion into cyber, climate resilience, and affordable-healthcare advisory services offers durable, secular growth opportunities beyond traditional broking. Second, cost-structure evolution—particularly synergy extraction from the McGriff deal and disciplined expense management—should support gradual margin sustainability, a point emphasized by multiple sell-side analysts.
Technology transitions are a double-edged sword: the firm can monetize data and analytics as clients digitize risk management, but it must also defend against technology-enabled intermediaries that could disintermediate parts of the value chain. Competitive threats from other large brokers and consulting firms remain, yet Marsh McLennan's scale and diversification provide meaningful insulation. Capital-allocation priorities—balancing deleveraging after a major acquisition against dividends, buybacks, and further M&A—will be closely watched. Consensus expectations project revenue near $28.6 billion for 2026 and roughly $30 billion for 2027, with earnings per share (EPS) growth in the high-single-digit range, implying analysts anticipate continued but measured expansion rather than a sharp reacceleration.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MRSH has been closely correlated with BRO. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRSH jumps, then BRO could also see price increases.
| Ticker / NAME | Correlation To MRSH | 1D Price Change % | ||
|---|---|---|---|---|
| MRSH | 100% | -0.37% | ||
| BRO - MRSH | 81% Closely correlated | -0.52% | ||
| AJG - MRSH | 80% Closely correlated | -0.34% | ||
| AON - MRSH | 78% Closely correlated | -0.80% | ||
| WTW - MRSH | 65% Loosely correlated | -0.35% | ||
| RYAN - MRSH | 59% Loosely correlated | -1.47% | ||
More | ||||
| Ticker / NAME | Correlation To MRSH | 1D Price Change % |
|---|---|---|
| MRSH | 100% | -0.37% |
| MRSH (5 stocks) | 84% Closely correlated | +4.52% |
| Insurance Brokers/Services (22 stocks) | 67% Closely correlated | +1.46% |
| Insurance (119 stocks) | 64% Loosely correlated | +0.02% |
Industry InsuranceBrokersServices
MRSH saw its Momentum Indicator move above the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 47 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 54%.
The Moving Average Convergence Divergence (MACD) for MRSH just turned positive on October 02, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in 27 of 50 cases over the following month. The odds of a continued upward trend are 54%.
MRSH moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 48%.
Following a +1.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 160 of 338 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
MRSH broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MRSH entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.989) is normal, around the industry mean (2.582). P/E Ratio (23.211) is within average values for comparable stocks, (17.872). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.021) settles around the average of (0.047) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (2.968).